Track Alcon Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Alcon Inc. ALC Open Alcon Inc. in new tab

65.95 USD
P/E
38.11
EPS
1.67
Yield
0.39%
P/B
1.40
ROE
3.71
Beta
0.70
Target Price
87.86 USD
Alcon Inc. logo

Alcon Inc.

🧾 Earnings Recap – Q1 2026

Alcon’s shares fell sharply by 14.2% following earnings, primarily reflecting investor disappointment with cautious outlook commentary and uneven market conditions in the cataract segment despite new product introductions.

  • Q1 experienced a mixed performance, with growth driven by new product launches and share gains in U.S. AT-IOLs, surgical equipment, consumables, contact lenses, and dry eye categories.
  • Cataract market conditions remained uneven, contributing to investor concern.
  • The Unity platform, including Unity VCS and Unity CS, showed promising momentum with strong surgeon engagement and an expanding installed base.
  • U.S. share gains in presbyopia-correcting IOLs largely supported by PanOptix Pro, with gradual international rollouts underway.
  • Early adoption of Valeda for dry AMD shows encouraging clinical potential, but broader market impact remains limited for now.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateMay 19, 2026
P/E38.11
EPS1.67
Book Value45.38
Price to Book1.40
Debt/Equity23.77
% Insiders0.175%
Growth
Revenue Growth0.09%
Earnings Growth-0.45%
Estimates
Forward P/E16.05
Forward EPS3.96
Target Mean Price87.86
Dividend
Dividend Yield0.39%
Annual dividends0.33 USD
Ex-Div. DateMay 6, 2026
Payout11.81%

DCF Valuation

Tweak assumptions to recompute fair value for Alcon Inc. (ALC)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Alcon Inc. Logo Alcon Inc. Analysis (ALC)

Switzerland Health Care Official Website Stock

Is Alcon Inc. a good investment? Alcon Inc. (ALC) is currently trading at 65.95 USD. Market analysts have a consensus price target of 87.86 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 38.11. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Alcon Inc. is expected to release its next earnings report on May 19, 2026. The market consensus estimate for Forward EPS is 3.96.

For income investors, Alcon Inc. pays a dividend yield of 0.39%. With a payout ratio of 12%, the dividend appears sustainable.

Investor FAQ

Does Alcon Inc. pay a dividend?

Yes, it pays an annual dividend of 0.33 USD (0.39% yield).

What asset class is Alcon Inc.?

Alcon Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be May 19, 2026. The company currently has a trailing EPS of 1.67.

Company Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Exchange Ticker
NYQ (United States) ALC
EBS (Ireland) ALC.SW
MEX (Mexico) ALCN.MX
Dividend Yield

0.39%

Annual Dividends

0.33 USD

Next ex. div date

May 6, 2026

Payout Ratio

11.81%

Historical Dividends
Year Total Dividends
2026 0.36 USD
2025 0.33 USD
2024 0.26 USD
2023 0.24 USD
2022 0.21 USD
2021 0.11 USD

Yearly aggregated dividends

Dividends

Alcon Inc.
May 07, 2026 Paid
Dividend
0.3583 USD

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion